David Hreniuk

1.4k total citations
28 papers, 1.2k citations indexed

About

David Hreniuk is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, David Hreniuk has authored 28 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 6 papers in Pathology and Forensic Medicine and 5 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in David Hreniuk's work include Cardiac Ischemia and Reperfusion (5 papers), Mitochondrial Function and Pathology (3 papers) and Cardiac electrophysiology and arrhythmias (3 papers). David Hreniuk is often cited by papers focused on Cardiac Ischemia and Reperfusion (5 papers), Mitochondrial Function and Pathology (3 papers) and Cardiac electrophysiology and arrhythmias (3 papers). David Hreniuk collaborates with scholars based in United States, Switzerland and Russia. David Hreniuk's co-authors include David R. Janero, H. Sharif, John A. Wagner, Patricia D. Wilson, Catherine L. Cioffi, Patricia A. Gabow, Kelem Kassahun, Brett P. Monia, Neal Azrolan and Donghui Cui and has published in prestigious journals such as Biochemical Journal, Biochemical and Biophysical Research Communications and FEBS Letters.

In The Last Decade

David Hreniuk

28 papers receiving 1.1k citations

Peers

Countries citing papers authored by David Hreniuk

Since Specialization

Citations

This map shows the geographic impact of David Hreniuk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Hreniuk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Hreniuk more than expected).

Fields of papers citing papers by David Hreniuk

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Hreniuk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Hreniuk. The network helps show where David Hreniuk may publish in the future.

Co-authorship network of co-authors of David Hreniuk

This figure shows the co-authorship network connecting the top 25 collaborators of David Hreniuk. A scholar is included among the top collaborators of David Hreniuk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Hreniuk. David Hreniuk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The Absolute Bioavailability and Effect of Food on the Pharmacokinetics of Odanacatib: A Stable-Label i.v./Oral Study in Healthy Postmenopausal Women 2016 ·Drug Metabolism and Disposition ·Stefan Zajic, Stefaan Rossenu, David Hreniuk, Filippos Kesisoglou, Jacqueline B. McCrea, Fang Liu, Linda Sun, Robert C. Witter, Donald R. Gauthier, (unknown), D. T. Joss, (unknown), R Stoltz, Julie A. Stone, S. Aubrey Stoch	6
2	Absence of clinically relevant drug-drug interaction between odanacatib and digoxin after concomitant administration 2013 ·International Journal of Clinical Pharmacology and Therapeutics ·S. Aubrey Stoch, (unknown), David Hreniuk, Chengcheng Liu, Stefan Zajic, Anish Mehta, (unknown), (unknown), (unknown), Daria Stypinski, Andrew Denker, John A. Wagner	7
3	Pharmacokinetics and Tolerability of Rizatriptan in Pediatric Migraineurs in a Randomized Study 2012 ·Headache The Journal of Head and Face Pain ·Iain P. Fraser, Lingling Han, Tae Hyung Han, Chi‐Chung Li, David Hreniuk, S. Aubrey Stoch, John A. Wagner, Steven L. Linder, Paul Winner	12
4	Single‐Dose Administration of MK‐0657, an NR2B‐Selective NMDA Antagonist, Does Not Result in Clinically Meaningful Improvement in Motor Function in Patients With Moderate Parkinson's Disease 2009 ·The Journal of Clinical Pharmacology ·Carol Addy, C. Assaid, David Hreniuk, Mark Stroh, Yang Xu, W. Joseph Herring, Aaron Ellenbogen, Hyder A. Jinnah, Louis Kirby, Mark Leibowitz, R. Malcolm Stewart, Daniel Tarsy, James W. Tetrud, S. Aubrey Stoch, Keith Gottesdiener, John A. Wagner	51
5	A Thorough QTc Study to Assess the Effect of Sitagliptin, a DPP4 Inhibitor, on Ventricular Repolarization in Healthy Subjects 2009 ·The Journal of Clinical Pharmacology ·Daniel M. Bloomfield, Rajesh Krishna, David Hreniuk, Lisa Hickey, Kalyan Ghosh, Arthur Bergman, Jutta Miller, María J. Gutiérrez, R Stoltz, Keith Gottesdiener, Gary Herman, John A. Wagner	28
6	Sitagliptin, an dipeptidyl peptidase‐4 inhibitor, does not alter the pharmacokinetics of the sulphonylurea, glyburide, in healthy subjects 2008 ·British Journal of Clinical Pharmacology ·Goutam C. Mistry, Arthur Bergman, Wei Zheng, David Hreniuk, Miguel A. Zinny, Keith Gottesdiener, John A. Wagner, Gary Herman, Marcella Ruddy	42
7	The Effect of Moxifloxacin on QTc and Implications for the Design of Thorough QT Studies 2008 ·Clinical Pharmacology & Therapeutics ·(unknown), (unknown), Kalyan Ghosh, David Hreniuk, (unknown), (unknown), (unknown), JA Wagner	130
8	Effects of Etoricoxib and Comparator Nonsteroidal Anti‐Inflammatory Drugs on Urinary Sodium Excretion, Blood Pressure, and Other Renal Function Indicators in Elderly Subjects Consuming a Controlled Sodium Diet 2007 ·The Journal of Clinical Pharmacology ·(unknown), Chau Thach, (unknown), Jutta Miller, David Hreniuk, (unknown), (unknown), B. J. Gertz, (unknown)	16
9	Metabolism and Disposition in Humans of Raltegravir (MK-0518), an Anti-AIDS Drug Targeting the Human Immunodeficiency Virus 1 Integrase Enzyme 2007 ·Drug Metabolism and Disposition ·Kelem Kassahun, Ian McIntosh, Donghui Cui, David Hreniuk, (unknown), Kenneth C. Lasseter, Neal Azrolan, Marian Iwamoto, John A. Wagner, Larissa Wenning	223
10	Inhibition of C-Jun N-Terminal Kinase 1, but Not c-Jun N-Terminal Kinase 2, Suppresses Apoptosis Induced by Ischemia/Reoxygenation in Rat Cardiac Myocytes 2001 ·Molecular Pharmacology ·David Hreniuk, (unknown), William A. Gaarde, Brett P. Monia, Robert A. McKay, Catherine L. Cioffi	107
11	Inhibition of C-Jun N-Terminal Kinase 1, but Not c-Jun N-Terminal Kinase 2, Suppresses Apoptosis Induced by Ischemia/Reoxygenation in Rat Cardiac Myocytes 2001 ·Molecular Pharmacology ·David Hreniuk, (unknown), William A. Gaarde, Brett P. Monia, Robert A. McKay, Catherine L. Cioffi	2
12	Identification and molecular characterization of a high‐affinity cardiomyocyte transforming growth factor‐β2 receptor 1993 ·FEBS Letters ·(unknown), David R. Janero, David Hreniuk	6
13	Radioiodination of transforming growth factor-β (TGF-β) in a modified Bolton-Hunter reaction system 1993 ·Journal of Biochemical and Biophysical Methods ·(unknown), David R. Janero, David Hreniuk, Lawrence P. Wennogle	3
14	Hydrogen peroxide‐induced oxidative stress to the mammalian heart‐muscle cell (cardiomyocyte): Nonperoxidative purine and pyrimidine nucleotide depletion 1993 ·Journal of Cellular Physiology ·David R. Janero, David Hreniuk, H. Sharif	23
15	Identification and biochemical characterization of a heart-muscle cell transforming growth factorβ-1 receptor 1993 ·Biochemical Pharmacology ·(unknown), David R. Janero, David Hreniuk	5
16	Isolation and characterization of AMP deaminase from mammalian (rabbit) myocardium 1993 ·Biochemical Journal ·(unknown), David R. Janero, (unknown), Hanisah Sharif, David Hreniuk	13
17	Hydroperoxide-induced oxidative stress alters pyridine nucleotide metabolism in neonatal heart muscle cells 1993 ·American Journal of Physiology-Cell Physiology ·David R. Janero, David Hreniuk, H. Sharif, (unknown)	32
18	A relationship between multidrug resistance and growth-state dependent cytotoxicity of the lysosomotropic detergent N-dodecylimidazole 1991 ·Biochemical and Biophysical Research Communications ·Patricia D. Wilson, David Hreniuk, John Lenard	9
19	Hydrogen peroxide‐induced oxidative stress to the mammalian heart‐muscle cell (cardiomyocyte): Lethal peroxidative membrane injury 1991 ·Journal of Cellular Physiology ·David R. Janero, David Hreniuk, H. Sharif	92
20	Reduced cytotoxicity of the lysosomotropic detergent N-dodecylimidazole after differentiation of HL60 promyelocytes. 1989 ·PubMed ·Patricia D. Wilson, David Hreniuk, John Lenard	13

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact